NCT Number: NCT00329095
An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance
This is an open-label study in patients who are currently using either a topical prostaglandin as sole ocular hypotensive medical therapy q.d., or a topical prostaglandin plus an adjunctive topical ocular hypotensive marketed product either q.d., or b.i.d. in the same eye(s). Compliance will be measured over the two months of participation.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
About this study
This is an open-label study in patients who are currently using either a topical prostaglandin as sole ocular hypotensive medical therapy q.d., or a topical prostaglandin plus an adjunctive topical ocular hypotensive marketed product either q.d., or b.i.d. in the same eye(s). Compliance will be measured over the two months of participation.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Currently using one or two topical ocular hypotensive medications
Exclusion criteria
- Hypersensitivity to any component of medication
Treatment and study plan
Additional ocular hypotensive medication
DrugPrimary outcomes
-
Compliance.
Sponsors and collaborators
Lead sponsor
Robin, Alan L., M.D.
Indiv
Registry information
Official study title
An Evaluation of Use of Topical Ocular Hypotensive Medication by Electronic Compliance Measures
Important dates
- Study start
- 2005
- Study completion
- 2006
- First posted
- May 24, 2006
- Registry last updated
- May 24, 2006
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
SD-OCT Multimodal Analysis in GLaucoma
NCT02710916
Eye Diseases, Glaucoma
Bordeaux, Aquitaine, France
View Trial Details24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
NCT06689696
Eye Diseases, GLAUCOMA 1, OPEN ANGLE, D (Disorder)
Fullerton, California, United States
View Trial DetailsEfficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension
NCT06394973
Eye Diseases, Glaucoma
Glendale, Arizona, United States
View Trial DetailsEvaluation of the Safety and Effectiveness of the Bimatoprost Implant System / IOL Combination in Patients With Ocular Hypertension or Mild to Moderate Open-angle Glaucoma
NCT07154797
Cataract, Eye Diseases
Santa Rosa de Copán, Honduras
View Trial Details